QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hwang, T.-L. Articles by Cheng, S. J.-S. Search for Related Content PubMed PubMed Citation Articles by Hwang, T.-L. Articles by Cheng, S. J.-S.

Soluble Guanylyl Cyclase Activator YC-1 Inhibits Human Neutrophil Functions through a cGMP-Independent but cAMP-Dependent Pathway

Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan, Taiwan (T.-L.H., H.-W.H., S.-H.K., S.J.-S.C.); Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan (C.-M.T.); and Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan (C.-C.W.)

3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1), a novel type of soluble guanylyl cyclase (sGC) activator, is useful in investigating the signaling of cGMP and may provide a new approach for treating cardiovascular diseases. Herein, YC-1 was demonstrated to inhibit the generation of superoxide anion () and the release of -glucuronidase release, to diminish the membrane-associated p47^phox and to accelerate resequestration of cytosolic calcium in formyl-L-methionyl-L-leucyl-L-phenylalanine-activated human neutrophils. YC-1 not only directly promoted sGC activity and cGMP formation but also dramatically potentiated sodium nitroprusside-induced sGC activity and cGMP formation in human neutrophils. However, the synergistic increase in the amount of cGMP was inconsistent with its cellular response. Moreover, neither an sGC inhibitor nor protein kinase G inhibitors reversed the inhibitory effect of YC-1. Interestingly, YC-1 also increased the cAMP concentration and protein kinase (PK)A activity. The inhibitory effect of YC-1 was significantly enhanced by prostaglandin (PG)E₁ and isoproterenol, and almost abolished by PKA inhibitors. These results show that cAMP, but not cGMP, mediates the YC-1-induced inhibition of human neutrophils. YC-1 increased the PGE₁- and forskolin-induced but not 3-isobutyl-1-methylxanthine-produced cAMP formation, suggesting inhibition of phosphodiesterase. These findings thus reveal novel mechanism-mediated anti-inflammatory properties of YC-1 in human neutrophils, which can influence the progression of cardiovascular disease. cAMP, but not cGMP, plays an important role in the regulation of respiratory burst and degranulation in human neutrophils.

Address correspondence to: Dr. Tsong-Long Hwang, Graduate Institute of Natural Products, College of Medicine, Chang Gung University, 259 Wen-Hwa 1st Rd., Kweishan 333, Taoyuan, Taiwan. E-mail: htl{at}mail.cgu.edu.tw

This article has been cited by other articles:

				B. Egemnazarov, A. Sydykov, R. T. Schermuly, N. Weissmann, J.-P. Stasch, A. S. Sarybaev, W. Seeger, F. Grimminger, and H. A. Ghofrani Novel soluble guanylyl cyclase stimulator BAY 41-2272 attenuates ischemia-reperfusion-induced lung injury Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L462 - L469. [Abstract] [Full Text] [PDF]

				X.-m. Liu, K. J. Peyton, N. N. Mendelev, H. Wang, D. A. Tulis, and W. Durante YC-1 Stimulates the Expression of Gaseous Monoxide-Generating Enzymes in Vascular Smooth Muscle Cells Mol. Pharmacol., January 1, 2009; 75(1): 208 - 217. [Abstract] [Full Text] [PDF]

				J. Zhang, Z. Xie, Y. Dong, S. Wang, C. Liu, and M.-H. Zou Identification of Nitric Oxide as an Endogenous Activator of the AMP-activated Protein Kinase in Vascular Endothelial Cells J. Biol. Chem., October 10, 2008; 283(41): 27452 - 27461. [Abstract] [Full Text] [PDF]

				M. Nanamori, J. Chen, X. Du, and R. D. Ye Regulation of Leukocyte Degranulation by cGMP-Dependent Protein Kinase and Phosphoinositide 3-Kinase: Potential Roles in Phosphorylation of Target Membrane SNARE Complex Proteins in Rat Mast Cells J. Immunol., January 1, 2007; 178(1): 416 - 427. [Abstract] [Full Text] [PDF]

				C. E. Teixeira, F. B. M. Priviero, and R. C. Webb Molecular Mechanisms Underlying Rat Mesenteric Artery Vasorelaxation Induced by the Nitric Oxide-Independent Soluble Guanylyl Cyclase Stimulators BAY 41-2272 [5-Cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 258 - 266. [Abstract] [Full Text] [PDF]

				S.-W. Wang, S.-L. Pan, J.-H. Guh, H.-L. Chen, D.-M. Huang, Y.-L. Chang, S.-C. Kuo, F.-Y. Lee, and C.-M. Teng YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] Exhibits a Novel Antiproliferative Effect and Arrests the Cell Cycle in G0-G1 in Human Hepatocellular Carcinoma Cells J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 917 - 925. [Abstract] [Full Text] [PDF]